Published in J Clin Immunol on August 07, 2009
Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets. BMC Med Genomics (2010) 1.09
Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective. Int J Med Sci (2012) 0.88
Menopause, complement, and hemostatic markers in women at midlife: the Study of Women's Health Across the Nation. Atherosclerosis (2013) 0.84
Radiological assessment of osteo-arthrosis. Ann Rheum Dis (1957) 42.98
Dendritic cell regulation of TH1-TH2 development. Nat Immunol (2000) 5.13
Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol (2006) 4.55
Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol (2006) 3.18
Sex hormones and the immune response in humans. Hum Reprod Update (2005) 3.13
The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol (1998) 2.50
Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol (2002) 2.33
Osteoimmunology: interactions of the bone and immune system. Endocr Rev (2008) 2.32
Regulation of the T cell response. Clin Exp Allergy (2006) 2.16
The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev (2005) 2.03
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A (2003) 1.75
Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol (2004) 1.72
Macrophage complement receptors and pathogen clearance. Cell Microbiol (2007) 1.65
Ins and outs of dendritic cells. Int Arch Allergy Immunol (2006) 1.16
Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann N Y Acad Sci (2006) 1.14
Estrogen deficiency, T cells and bone loss. Cell Immunol (2007) 1.09
Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J Immunol (2009) 1.05
Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol (1996) 1.02
Immune responses and bone loss: the estrogen connection. Immunol Rev (2005) 1.02
A three-cell model for activation of naïve T helper cells. Scand J Immunol (2006) 1.02
Estrogen regulation of immune cell bone interactions. Ann N Y Acad Sci (2006) 0.96
Immunocompetent properties of human osteoblasts: interactions with T lymphocytes. J Bone Miner Res (2005) 0.94
Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause (2001) 0.93
Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol (2005) 0.90
Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy. Gynecol Obstet Invest (2001) 0.89
Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women. Calcif Tissue Int (2007) 0.82
Influence of estrogen deficiency and replacement on T-cell populations in rat lymphoid tissues and organs. Endocrine (2000) 0.80
17beta-Estradiol and soy phytochemicals selectively induce a type 2 polarization in mesenteric lymph nodes of ovariectomized rats. Menopause (2008) 0.78
Estrogen effects on protein expressed by marrow stromal osteoblasts. Biochem Biophys Res Commun (1997) 0.76
Complement receptors and B lymphocytes. Crit Rev Immunol (2004) 0.75
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation (2005) 3.31
Phase entrainment of human delta oscillations can mediate the effects of expectation on reaction speed. J Neurosci (2010) 1.84
Intraoperative determination of PTH concentrations in fine needle tissue aspirates to identify parathyroid tissue during parathyroidectomy. World J Surg (2010) 1.45
[Review of the application of synthetic bone grafts. The role of the gypsum in bone substitution: molecular biological approach, based on own research results]. Orv Hetil (2007) 1.38
Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol (2003) 1.33
The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. J Histochem Cytochem (2009) 1.30
Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res Clin Pract (2002) 1.05
Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. J Bone Miner Res (2004) 1.01
Marked increase in CYP24A1 gene expression in human papillary thyroid cancer. Thyroid (2011) 0.95
The impact of minimally invasive total hip arthroplasty on the standard procedure. Int Orthop (2006) 0.94
Relationship between serum calcium and CA 19-9 levels in colorectal cancer. World J Gastroenterol (2004) 0.94
Sub-terminal sequences modulating IS30 transposition in vivo and in vitro. J Mol Biol (2007) 0.94
The disease burden of colorectal cancer in Hungary. Eur J Health Econ (2010) 0.93
Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflamm Bowel Dis (2007) 0.93
Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav (2012) 0.92
Retrograde genocephalic removal of fractured or immovable femoral stems in revision hip surgery. Hip Int (2010) 0.91
Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. Eur J Endocrinol (2002) 0.91
Transposition and targeting of the prokaryotic mobile element IS30 in zebrafish. FEBS Lett (2003) 0.91
Effect of deviant probability and interstimulus/interdeviant interval on the auditory N1 and mismatch negativity in the cat auditory cortex. Brain Res Cogn Brain Res (2002) 0.90
Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene. J Mol Neurosci (2014) 0.90
Synchronous multiple glomus tumors of the esophagus and lung. Hepatogastroenterology (2003) 0.90
Impaired cerebrovascular reactivity in sepsis-associated encephalopathy studied by acetazolamide test. Crit Care (2010) 0.90
Effect of gypsum on proliferation and differentiation of MC3T3-E1 mouse osteoblastic cells. Biomaterials (2006) 0.90
Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population. BMC Cancer (2008) 0.89
Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration. Anticancer Res (2012) 0.89
Psychosocial, educational, and somatic factors in chronic nonspecific low back pain. Rheumatol Int (2012) 0.89
Novel genetic mutation in the background of Carney complex. Pathol Oncol Res (2012) 0.88
The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells. Bone (2011) 0.87
CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells. World J Gastroenterol (2013) 0.87
Immune complex signatures of patients with active and inactive SLE revealed by multiplex protein binding analysis on antigen microarrays. PLoS One (2012) 0.87
Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2002) 0.86
Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study. J Clin Densitom (2012) 0.85
[Squamous papilloma of the esophagus. Clinical and pathological observations based on 172 papillomas in 155 patients]. Orv Hetil (2005) 0.85
Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int (2006) 0.84
Detection and analysis of transpositionally active head-to-tail dimers in three additional Escherichia coli IS elements. Microbiology (2003) 0.84
Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases. Pathol Oncol Res (2009) 0.84
Morphological changes in the lower esophageal sphincter influencing the result of antireflux surgical interventions in chronic gastroesophageal reflux disease. Hepatogastroenterology (2006) 0.83
Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk. Eur J Endocrinol (2008) 0.83
Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2005) 0.83
[Verner-Morrison syndrome: a case study]. Orv Hetil (2010) 0.83
Gene expression changes in femoral head necrosis of human bone tissue. Dis Markers (2011) 0.83
[Change in location of colorectal cancer in Hungarian patients between 1993-2004]. Orv Hetil (2006) 0.83
[Changes in surgical therapy of pulmonary hydatid cysts]. Magy Seb (2004) 0.83
[Experiences with price competition of biosimilar drugs in Hungary]. Acta Pharm Hung (2014) 0.83
Disc degeneration-related clinical phenotypes. Eur Spine J (2013) 0.82
Combined high tibial osteotomy decreases biomechanical changes radiologically detectable in the sagittal plane compared with closing-wedge osteotomy. Arthroscopy (2009) 0.82
Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women. Calcif Tissue Int (2007) 0.82
Identifying novel genes involved in both deer physiological and human pathological osteoporosis. Mol Genet Genomics (2008) 0.81